103 related articles for article (PubMed ID: 1477528)
1. Reorganization of cingulate cortex in Alzheimer's disease: neuron loss, neuritic plaques, and muscarinic receptor binding.
Vogt BA; Crino PB; Vogt LJ
Cereb Cortex; 1992; 2(6):526-35. PubMed ID: 1477528
[TBL] [Abstract][Full Text] [Related]
2. Laminar alterations in gamma-aminobutyric acidA, muscarinic, and beta adrenoceptors and neuron degeneration in cingulate cortex in Alzheimer's disease.
Vogt BA; Crino PB; Volicer L
J Neurochem; 1991 Jul; 57(1):282-90. PubMed ID: 1675662
[TBL] [Abstract][Full Text] [Related]
3. Laminar distribution of neuron degeneration in posterior cingulate cortex in Alzheimer's disease.
Vogt BA; Van Hoesen GW; Vogt LJ
Acta Neuropathol; 1990; 80(6):581-9. PubMed ID: 1703381
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease.
Piggott MA; Owens J; O'Brien J; Colloby S; Fenwick J; Wyper D; Jaros E; Johnson M; Perry RH; Perry EK
J Chem Neuroanat; 2003 Mar; 25(3):161-73. PubMed ID: 12706204
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic receptor binding increases in anterior thalamus and cingulate cortex during discriminative avoidance learning.
Vogt BA; Gabriel M; Vogt LJ; Poremba A; Jensen EL; Kubota Y; Kang E
J Neurosci; 1991 Jun; 11(6):1508-14. PubMed ID: 2045875
[TBL] [Abstract][Full Text] [Related]
6. Experimental localization of muscarinic receptor subtypes to cingulate cortical afferents and neurons.
Vogt BA; Burns DL
J Neurosci; 1988 Feb; 8(2):643-52. PubMed ID: 3339431
[TBL] [Abstract][Full Text] [Related]
7. The distribution of M1 and M2 muscarinic acetylcholine receptor subtypes in the developing cat visual cortex.
Prusky G; Cyander M
Brain Res Dev Brain Res; 1990 Oct; 56(1):1-12. PubMed ID: 2279321
[TBL] [Abstract][Full Text] [Related]
8. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease.
Arnold SE; Hyman BT; Flory J; Damasio AR; Van Hoesen GW
Cereb Cortex; 1991; 1(1):103-16. PubMed ID: 1822725
[TBL] [Abstract][Full Text] [Related]
9. Limbic thalamus in rabbit: architecture, projections to cingulate cortex and distribution of muscarinic acetylcholine, GABAA, and opioid receptors.
Vogt LJ; Vogt BA; Sikes RW
J Comp Neurol; 1992 May; 319(2):205-17. PubMed ID: 1326004
[TBL] [Abstract][Full Text] [Related]
10. Laminar distributions of muscarinic acetylcholine, serotonin, GABA and opioid receptors in human posterior cingulate cortex.
Vogt BA; Plager MD; Crino PB; Bird ED
Neuroscience; 1990; 36(1):165-74. PubMed ID: 1977100
[TBL] [Abstract][Full Text] [Related]
11. Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations.
Ladner CJ; Lee JM
Exp Neurol; 1999 Aug; 158(2):451-8. PubMed ID: 10415152
[TBL] [Abstract][Full Text] [Related]
12. Multivariate analysis of laminar patterns of neurodegeneration in posterior cingulate cortex in Alzheimer's disease.
Vogt BA; Vogt LJ; Vrana KE; Gioia L; Meadows RS; Challa VR; Hof PR; Van Hoesen GW
Exp Neurol; 1998 Sep; 153(1):8-22. PubMed ID: 9743563
[TBL] [Abstract][Full Text] [Related]
13. Preservation of acetylcholine muscarinic M2 receptor G-protein interactions in the neocortex of patients with Alzheimer's disease.
Hérnandez-Hérnandez A; Adem A; Ravid R; Cowburn RF
Neurosci Lett; 1995 Feb; 186(1):57-60. PubMed ID: 7783950
[TBL] [Abstract][Full Text] [Related]
14. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
Gillard M; Waelbroeck M; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
[TBL] [Abstract][Full Text] [Related]
15. The pathogenesis of cingulate atrophy in behavioral variant frontotemporal dementia and Alzheimer's disease.
Tan RH; Pok K; Wong S; Brooks D; Halliday GM; Kril JJ
Acta Neuropathol Commun; 2013 Jul; 1():30. PubMed ID: 24252534
[TBL] [Abstract][Full Text] [Related]
16. Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia.
Newell KA; Zavitsanou K; Jew SK; Huang XF
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):225-33. PubMed ID: 16901598
[TBL] [Abstract][Full Text] [Related]
17. Differential modification of muscarinic cholinergic receptors in the hippocampus of patients with Alzheimer's disease: an autoradiographic study.
Probst A; Cortés R; Ulrich J; Palacios JM
Brain Res; 1988 May; 450(1-2):190-201. PubMed ID: 3401711
[TBL] [Abstract][Full Text] [Related]
18. Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration.
Lee W; Wolfe BB
Mol Pharmacol; 1989 Nov; 36(5):749-57. PubMed ID: 2555673
[TBL] [Abstract][Full Text] [Related]
19. Multiple heteroreceptors on limbic thalamic axons: M2 acetylcholine, serotonin1B, beta 2-adrenoceptors, mu-opioid, and neurotensin.
Vogt BA; Crino PB; Jensen EL
Synapse; 1992 Jan; 10(1):44-53. PubMed ID: 1311129
[TBL] [Abstract][Full Text] [Related]
20. Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of Alzheimer-type patients.
Lang W; Henke H
Brain Res; 1983 May; 267(2):271-80. PubMed ID: 6871676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
